lobbying_activities: 2969909

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2969909	17d496e9-615e-4048-85dd-19aed7505b5f	Q1	ERVIN GRAVES STRATEGY GROUP, LLC	13836	EMERGENT BIOSOLUTIONS INC.	2023	first_quarter	DIS	"Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield State opioid response (SOR) Grant funding NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone "	Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2023-04-19T14:11:57-04:00